Traits, trends and hits of orphan drug designations in cystic fibrosisEnrico Costa, Hubert G. M. Leufkens, Hendrika A. van den Ham et al.|Journal of Cystic Fibrosis|2023Cited by 6
Medicines not recommended for inclusion in the who essential medicines list: a retrospective observational studyEnrico Costa, Lorenzo Moja, Armando A. Genazzani et al.|Frontiers in Medicine|2025Cited by 2
Challenges and opportunities of adding CFTR modulators for cystic fibrosis to the WHO essential medicines listEnrico Costa, Hubert G. M. Leufkens, Hendrika A. van den Ham|Journal of Cystic Fibrosis|2025Cited by 2